Indolyl derivatives as liver-x-receptor modulators

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 413/06 (2006.01) A61K 31/404 (2006.01) A61P 3/06 (2006.01) C07D 209/08 (2006.01) C07D 209/12 (2006.01) C07D 209/30 (2006.01) C07D 401/06 (2006.01) C07D 403/06 (2006.01) C07D 409/06 (2006.01) C07D 413/10 (2006.01) C07D 417/06 (2006.01)

Patent

CA 2564563

Compounds of formula (I) (see formula I) or pharmaceutically acceptable salts or pharmaceutically acceptable esters thereof, wherein R1, R2, R3, R4, R5, R6, A, m, n and p are defined as in claim 1. These compounds can be used as medicaments in the treatment of diseases such as atherosclerosis and diabetes.

L'invention concerne des composés représentés par la formule (I) ainsi que des sels pharmaceutiquement acceptables et des esters pharmaceutiquement acceptables de celle-ci, dans laquelle R?1¿, R?2¿, R?3¿, R?4¿, R?5¿, R?6¿, A, m, n et p sont tels que définis dans la revendication 1. Ces composés peuvent être utilisés en tant que médicaments dans le traitement de maladies telles que l'athérosclérose et le diabète.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Indolyl derivatives as liver-x-receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indolyl derivatives as liver-x-receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolyl derivatives as liver-x-receptor modulators will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1615992

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.